Printer's No. PN1645
See other bills
under the
same topic PRINTER'S NO. 1645 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.286 Session of 2026 INTRODUCED BY MALONE, TARTAGLIONE, HUGHES, COLLETT, HAYWOOD, VOGEL, STREET AND CAPPELLETTI, APRIL 23, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, APRIL 23, 2026 A RESOLUTIONDesignating the month of May 2026 as "Ehlers-Danlos Syndrome Awareness Month" in Pennsylvania.WHEREAS, Ehlers-Danlos syndrome (EDS) is a group of 13 genetic disorders characterized by changes that impair the structure and function of connective tissues such as collagen; andWHEREAS, EDS can affect an individual's skin, joints, blood vessels, gastrointestinal system and other organs and tissues; andWHEREAS, Depending on the type of EDS, a wide range of features may be present, varying from mild to life-threatening, which may include joint hypermobility, skin hyperextensibility, tissue fragility, aneurysms and cardiac complications; andWHEREAS, Common signs and symptoms of EDS may include fragile skin with delayed wound healing, easy bruising, bleeding and atypical scarring; andWHEREAS, Misdiagnosis is common because these features often resemble other conditions, delaying accurate diagnosis and 123456789101112131415161718 complicating effective management; andWHEREAS, EDS is a chronic, lifelong condition that, according to the Ehlers-Danlos Society, affects approximately one in 5,000 people; andWHEREAS, According to the EDS Clinic, it is estimated that between 60,000 and 3 million Americans live with EDS; andWHEREAS, Several types of EDS are often underrecognized in primary care settings and may be misattributed to other disorders, meaning its true prevalence is likely higher; andWHEREAS, It is important for individuals with EDS to receive knowledgeable, compassionate care from professionals who understand these rare and complex disorders; andWHEREAS, Many people with EDS require a multidisciplinary team involving specialists from several fields to effectively manage their care; andWHEREAS, Even when two people have the same type of EDS, their symptoms can vary widely, and they may respond differently to various management approaches; andWHEREAS, Knowing the true prevalence of EDS will help direct resources for better diagnosis, treatment and research; andWHEREAS, Continued awareness and advocacy will move us towards a future with long-awaited medical breakthroughs for which patients and families affected by EDS have hoped; therefore be itRESOLVED, That the Senate designate the month of May 2026 as "Ehlers-Danlos Syndrome Awareness Month" in Pennsylvania.20260SR0286PN1645 - 2 - 1234567891011121314151617181920212223242526
under the
same topic PRINTER'S NO. 1645 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.286 Session of 2026 INTRODUCED BY MALONE, TARTAGLIONE, HUGHES, COLLETT, HAYWOOD, VOGEL, STREET AND CAPPELLETTI, APRIL 23, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, APRIL 23, 2026 A RESOLUTIONDesignating the month of May 2026 as "Ehlers-Danlos Syndrome Awareness Month" in Pennsylvania.WHEREAS, Ehlers-Danlos syndrome (EDS) is a group of 13 genetic disorders characterized by changes that impair the structure and function of connective tissues such as collagen; andWHEREAS, EDS can affect an individual's skin, joints, blood vessels, gastrointestinal system and other organs and tissues; andWHEREAS, Depending on the type of EDS, a wide range of features may be present, varying from mild to life-threatening, which may include joint hypermobility, skin hyperextensibility, tissue fragility, aneurysms and cardiac complications; andWHEREAS, Common signs and symptoms of EDS may include fragile skin with delayed wound healing, easy bruising, bleeding and atypical scarring; andWHEREAS, Misdiagnosis is common because these features often resemble other conditions, delaying accurate diagnosis and 123456789101112131415161718 complicating effective management; andWHEREAS, EDS is a chronic, lifelong condition that, according to the Ehlers-Danlos Society, affects approximately one in 5,000 people; andWHEREAS, According to the EDS Clinic, it is estimated that between 60,000 and 3 million Americans live with EDS; andWHEREAS, Several types of EDS are often underrecognized in primary care settings and may be misattributed to other disorders, meaning its true prevalence is likely higher; andWHEREAS, It is important for individuals with EDS to receive knowledgeable, compassionate care from professionals who understand these rare and complex disorders; andWHEREAS, Many people with EDS require a multidisciplinary team involving specialists from several fields to effectively manage their care; andWHEREAS, Even when two people have the same type of EDS, their symptoms can vary widely, and they may respond differently to various management approaches; andWHEREAS, Knowing the true prevalence of EDS will help direct resources for better diagnosis, treatment and research; andWHEREAS, Continued awareness and advocacy will move us towards a future with long-awaited medical breakthroughs for which patients and families affected by EDS have hoped; therefore be itRESOLVED, That the Senate designate the month of May 2026 as "Ehlers-Danlos Syndrome Awareness Month" in Pennsylvania.20260SR0286PN1645 - 2 - 1234567891011121314151617181920212223242526
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.